Children suffering from bronchial asthma, and their parents, can now breathe easier as a smart way to treat the most common chronic respiratory disease in children has been invented.
Through a one-stop nebulization process and an intelligent nebulization system, AstraZeneca has used Internet of Things (IoT)-based respiratory solution to enable children to receive more timely, standardized, and personalized treatment.
In the People's Hospital of Wuxi in East China's Jiangsu province, where AstraZeneca has its R&D and production base, children receiving nebulization treatment are enjoying cartoon shows in bright-colored environment. Without the system two years ago, parents had to coax the crying children while doctors and nurse were unavailable because their hands were full.
During the 10-minute-or-so treatment, parents will learn from medical instruction videos on the screen while their children enjoy the cartoon; a data screen in the clinic will show a map of nebulization treatment centers of the nation; a cellphone app will show parents the nearest treatment spot, not necessarily a crowded large general hospital.
According to the White Paper on Children's Respiratory Health, among children aged 0-14, the incidence of respiratory diseases is the highest at 51.87%. Data from the third epidemiological survey of pediatric asthma in Chinese cities shows that the total prevalence of asthma in children living in major Chinese cities is 3.02%.
Leon Wang, executive vice-president of AstraZeneca, said pharmaceuticals industry should focus more on patients instead of just teaching doctors how to treat patients.
IoT in the pharmaceuticals industry, for Wang, is a kind of restructuring in marketing. Together with related sectors such as hospitals, medical equipment companies and internet service providers, AstraZeneca aims to build a new ecology of health with all the necessary resources on the platform of big data.
According to Wang, more than 12,900 standard nebulization centers covering over 260 cities nationwide have been built and 122 chest pain centers have been set up by 2016.
Beyond China, countries involved in the Belt and Road Initiative are the next destinations. The first nebulization center aboard will be built in Cambodia later in September. More will open in other countries in Southeast Asia.
Source: China Daily, edited by APBN
Click here for the complete issue.